Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial

NCT07061184 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome - Diarrhoea
Traditional Chinese Medicine (TCM)
N of 1 Study Design
Efficacy and Safety

Interventions

DRUG: FLCWK
DRUG: Placebo

Sponsor

Peking Union Medical College Hospital